Abstract
Objectives
Chronic kidney disease (CKD) is increasingly prevalent in patients undergoing mitral valve replacement (MVR). While CKD is known to result in suboptimal outcomes for patients with mitral valve disease, there is limited literature evaluating the long-term outcomes and cardiac remodeling of patients with CKD undergoing MVR. We present the first analysis coupling long-term outcomes of combined morbidity, mortality, and cardiac remodeling post-MVR in patients with CKD.
Methods
Patients with varying degrees of CKD undergoing MVR from 2004 to 2018 were compared. Patients were grouped by estimated glomerular filtration rate (eGFR) > 90 mL/min/1.73m2 (n = 109), 60–89 mL/min/1.73m2 (450), 30–59 mL/min/1.73m2 (449), < 30 mL/min/1.73m2 (60). The primary outcome was mortality. Secondary outcomes included measures of postoperative morbidity and cardiac remodeling.
Results
One-year mortality was significantly increased in patients with eGFR < 30 (p = 0.023). Mortality at 7 years was significantly increased in patients with eGFR < 30 mL/min/1.73m2 (p < 0.001). Multivariable regression analysis of 7-year all-cause mortality indicated an eGFR of 15 mL/min/1.73m2 (HR 4.03, 95% CI 2.54–6.40) and 30 mL/min/1.73m2 (HR 2.17 95% CI 1.55–3.05) were predictive of increased mortality. Reduced eGFR predicted the development of postoperative sepsis (p = 0.002), but not other morbidities. Positive cardiac remodeling of the left ventricle, left atrium, and valve gradients were identified postoperatively for patients with eGFR > 30 mL/min/1.73m2 while patients with eGFR < 30 mL/min/1.73m2 did not experience the same changes.
Conclusions
CKD is predictive of inferior clinical and echocardiographic outcomes in patients undergoing MVR and consequently requires careful preoperative consideration and planning. Further investigation into optimizing the postoperative outcomes of this patient population is necessary.
Graphical abstract
Similar content being viewed by others
Availability of data and materials
Data are available within the article or its supplementary materials.
Code availability
Not applicable.
References
Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M et al (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395:709–733
Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D et al (2020) US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis 75:A6-7
Samad Z, Sivak JA, Phelan M, Schulte PJ, Patel U, Velazquez EJ (2017) Prevalence and outcomes of left-sided valvular heart disease associated with chronic kidney disease. J Am Heart Assoc 6:1–14
Matsuo H, Dohi K, Machida H, Takeuchi H, Aoki T, Nishimura H et al (2018) Echocardiographic assessment of cardiac structural and functional abnormalities in patients with end-stage renal disease receiving chronic hemodialysis. Circ J 82:586–595
Ureña-Torres P, D’Marco L, Raggi P, García-Moll X, Brandenburg V, Mazzaferro S, Lieber A, Guirado L, Bover J (2021) Valvular heart disease and calcification in CKD: More common than appreciated. Nephro Dial Transpl 35:2046–2053
Lo KB, Dayanand S, Ram P, Dayanand P, Slipczuk LN, Figueredo VM, Rangaswami J (2018) Interrelationship between kidney function and percutaneous mitral valve interventions: a comprehensive review. Curr Cardiol Rev 15:76–82
Jesri A, Braitman LE, Pressman GS (2008) Severe mitral annular calcification predicts chronic kidney disease. Int J Cardiol 128:193–196
Hoevelmann J, Mahfoud F, Lauder L, Scheller B, Böhm M, Ewen S (2021) Valvular heart disease in patients with chronic kidney disease. Herz 46:228–233
Hensen LCR, el Mahdiui M, van Rosendael AR, Smit JM, Jukema JW, Bax JJ, Delgado V (2018) Prevalence and prognostic implications of mitral and aortic valve calcium in patients with chronic kidney disease. Am J Cardiol 122:1732–1737
Thourani VH, Sarin EL, Kilgo PD, Lattouf OM, Puskas JD, Chen EP, Guyton RA (2012) Short- and long-term outcomes in patients undergoing valve surgery with end-stage renal failure receiving chronic hemodialysis. J Thorac Cardiovasc Surg 144:117–123
Thourani VH, Keeling WB, Sarin EL, Guyton RA, Kilgo PD, Dara AB, Puskas JD, Chen EP, Cooper WA, Vega JD, Morris CD, Halkos ME, Lattouf OM (2011) Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement. Ann Thorac Surg 91:1798–1807
Marwick TH, Amann K, Bangalore S, Cavalcante JL, Charytan DM, Craig JC, Gill JS, Hlatky MA, Jardine AG, Landmesser U, Newby LK, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, Sarnak MJ (2019) Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 96:836–849
Wang A, Sangli C, Lim S, Ailawadi G, Kar S, Herrmann HC, Grayburn P, Foster E, Weissman NJ, Glower D, Feldman T (2015) Evaluation of renal function before and after percutaneous mitral valve repair. Circ Cardiovasc Interven 8:1–8
Kaneko H, Neuss M, Schau T, Weissenborn J, Butter C (2017) Interaction between renal function and percutaneous edge-to-edge mitral valve repair using MitraClip. J Cardiol 69:476–482
Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR (2015) Mitral annulus calcification. J Am Coll Cardiol 66:1934–1941
Kuźma Ł, Małyszko J, Bachórzewska-Gajewska H, Niwińska MM, Kurasz A, Zalewska-Adamiec M, Kożuch M, Dobrzycki S (2020) Impact of chronic kidney disease on long-term outcome of patients with valvular heart defects. Int Urol Nephrol 52:2161–2170
Gultekin B, Ozkan S, Uguz E, Atalay H, Akay T, Arslan A, Sezgin A, Ozdemir N, Tasdelen A, Aslamaci S (2005) Valve replacement surgery in patients with end-stage renal disease: long-term results. Artific Organ 29:972–975
Dave P, Abunassar JG, Sayed N, Sharma S, Babiolakis CS, Bisleri G, Abuzeid W (2021) The effect of transcatheter mitral valve repair on short-term mortality in patients with chronic kidney disease: a systematic review and meta-analysis. Cardiovasc Revasc Med 30:78–84
Nagendran J, Bozso SJ, Norris CM, McAlister FA, Appoo JJ, Moon MC, Freed DH, Nagendran J (2018) Coronary artery bypass surgery improves outcomes in patients with diabetes and left ventricular dysfunction. J Am Coll Cardiol 71:819–827
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
Manghelli JL, Carter DI, Khiabani AJ, Gauthier JM, Moon MR, Munfakh NA, Damiano RJ, Corvera JS, Melby SJ (2019) A 20-year multicenter analysis of dialysis-dependent patients who had aortic or mitral valve replacement: implications for valve selection. J Thorac Cardiovasc Surg 158:805-813.e2
James MT, Laupland KB, Tonelli M, Manns BJ, Culleton BF, Hemmelgarn BR (2008) Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Archive Intern Med 168:2333–2339
Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ, Shlipak MG (2012) The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis 59:356–363
Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimbürger O, Cederholm T, Girndt M (2005) IL-10, IL-6, and TNF-α: central factors in the altered cytokine network of uremia - The good, the bad, and the ugly. Kidney Int 67:1216–1233
Karamnov S, Brovman EY, Greco KJ, Urman RD (2018) Risk factors and outcomes associated with sepsis after coronary artery bypass and open heart valve surgeries. Semin Cardiothorac Vasc Anesth 22:359–368
Bonow RO, Carabello B, de Leon AC, Edmunds LH, Fedderly BJ, Freed MD et al (1998) Guidelines for the management of patients with valvular heart disease. Circulation 98:1949–1984
Chan V, Chen L, Mesana L, Mesana TG, Ruel M (2011) Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: a systematic review and meta-analysis. Heart 97:2033–2037
Williams ML, Bavaria JE, Acker MA, Desai ND, Vallabhajosyula P, Hargrove WC, Atluri P, Szeto WY (2016) Valve selection in end-stage renal disease: should it always be biological? Ann Thorac Surg 102:1531–1535
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F et al (2021) 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77:e25-197
Funding
University Hospital Foundation, University of Alberta.
Author information
Authors and Affiliations
Contributions
REL-A: Study design, data collection, data analysis, data interpretation, writing of the manuscript, approval of final manuscript. SJB: Study design, data analysis, data interpretation, writing of the manuscript, approval of final manuscript. NMF: Study design, data analysis, data interpretation, writing of the manuscript, approval of final manuscript. JJHK: Study design, data analysis, data interpretation, writing of the manuscript, approval of final manuscript. DB: Study design, data collection, data interpretation, proof reading and revisions, approval of final manuscript. YH: Study design, data analysis, data interpretation, proof reading and revisions, approval of final manuscript. MCM: Study design, data interpretation, proof reading and revisions, approval of final manuscript. DHF: Study design, data interpretation, proof reading and revisions, approval of final manuscript. JN: Study design, data interpretation, proof reading and revisions, approval of final manuscript. JN: Study design, data interpretation, proof reading and revisions, approval of final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All authors have nothing to disclose.
Ethical approval
The local research ethics board provided approval for study ID Pro00103944 on August 31, 2020 with individual waiver for consent.
Consent to participate
Not applicable.
Consent to publication
Not applicable.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
EL-Andari, R., Bozso, S.J., Fialka, N.M. et al. The influence of renal disease on outcomes and cardiac remodeling following surgical mitral valve replacement. Clin Res Cardiol 112, 656–666 (2023). https://doi.org/10.1007/s00392-023-02153-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-023-02153-z